diabetes

Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Sun, 01/27/13 - 11:25 am
Takeda
diabetes
type 2 diabetes
Actos
alogliptin
Furiex Pharmaceuticals
Glaxo Plaintiff Lawyers Settle Dispute Over $143 Million
Bloomberg
Wed, 01/23/13 - 10:30 am
GSK
Avandia
diabetes
Big Pharma Diabetes Face-Off
The Motley Fool
Sat, 01/19/13 - 11:07 am
Pharma
diabetes
Bristol-Myers Squibb
Astra Zeneca
Novo Nordisk
GlaxoSmithKline
UPDATE: GI Dynamics launches U.S. EndoBarrier diabetes trial
Mass Device
Tue, 01/15/13 - 11:13 pm
GI Dynamics
EndoBarrier
diabetes
clinical trials
GSK files for U.S. approval of new diabetes drug
Reuters
Mon, 01/14/13 - 12:04 pm
GSK
diabetes
albiglutide
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Mon, 01/14/13 - 12:00 pm
JNJ
diabetes
FDA
canagliflozin
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Sat, 01/12/13 - 11:05 am
JNJ
canagliflozin
diabetes
type 2 diabetes
FDA Panel Backs Novel Diabetes Pill From J&J
Motley Fool
Fri, 01/11/13 - 11:38 am
FDA
advisory panels
JNJ
diabetes
canagliflozin
J&J Diabetes Drug Faces Questions at FDA Advisory Panel
Motley Fool
Thu, 01/10/13 - 09:49 am
diabetes
FDA
JNJ
advisory panel
canagliflozin
J&J Diabetes Pill May Have Heart Risks, FDA Staff Says
Bloomberg
Tue, 01/8/13 - 09:01 am
FDA
diabetes
JNJ
Invokana
Intarcia Says It’s in Partner Talks Beyond Diabetes Drugs
Bloomberg
Mon, 01/7/13 - 07:06 pm
Intarcia
diabetes
ITCA 650
Big News for These 2 Diabetes Hopefuls
Motley Fool
Mon, 01/7/13 - 06:52 pm
diabetes
empagliflozin
Eli Lilly
Invokana
JNJ
3 Big Stories Health-Care Investors Should Be Watching This Week
Motley Fool
Mon, 01/7/13 - 10:23 am
JNJ
Invokana
SLGT-2 inhibitors
diabetes
Forxiga
Bristol-Myers Squibb
Pfizer
Raptor Pharmaceuticals
Assessing Arena's Belviq As A Diabesity Drug
Seeking Alpha
Wed, 12/12/12 - 10:17 am
Belviq
Arena Pharmaceuticals
obesity
diabetes
Janssen submits NDA to FDA for canagliflozin/metformin
Yahoo/Fly on the Wall
Wed, 12/12/12 - 10:01 am
Janssen
FDA
canagliflozin
diabetes
metformin
The Next Wave of Diabetes Dominance
Motley Fool
Wed, 12/12/12 - 08:11 am
diabetes
Bayer
Sanofi
Novo Nordisk
Abbott Labs
Bristol-Myers Squibb
Sanofi's last on the list to buy Bayer's glucose devices
Mass Device
Mon, 12/10/12 - 12:08 pm
Sanofi
M&A
Bayer
diabetes
Bayer diabetes unit sale unlikely - sources
Reuters
Fri, 12/7/12 - 10:37 am
Bayer
diabetes
M&A
Sanofi
Diabetes: Medtronic wins CE Mark for Sentrino continuous glucose monitor
Tue, 12/4/12 - 11:05 pm
diabetes
Medtronic
CE Mark
Sentrino
glucose monitors
Glaxo Doubts GLP-1s Would Be Cleared as Drugs for Obesity
Bloomberg
Tue, 12/4/12 - 11:55 am
GSK
GLP-1 agonist
obesity
diabetes
albiglutide
Victoza
Novo Nordisk

Pages